Researchers at the University of Pennsylvania have identified a unique population of "pioneer" cells that appear in the lungs following severe injury, such as viral pneumonia. These cells are essential…
Insilico Medicine has advanced the first generative AI-discovered and AI-designed drug candidate into Phase II clinical trials. The drug, INS018_055, targets idiopathic pulmonary fibrosis, a chronic condition that causes progressive…
An international research consortium has integrated data from nearly 50 studies to create the Human Lung Cell Atlas, the most detailed map of the respiratory system ever produced. This open-access…
